Literature DB >> 10746568

Molecular analysis of the genotype-phenotype relationship in factor X deficiency.

D S Millar1, L Elliston, P Deex, M Krawczak, A I Wacey, J Reynaud, H K Nieuwenhuis, P Bolton-Maggs, P M Mannucci, J C Reverter, P Cachia, K J Pasi, D M Layton, D N Cooper.   

Abstract

Factor X deficiency is a rare haemorrhagic condition, normally inherited as an autosomal recessive trait, in which a variable clinical presentation correlates poorly with laboratory phenotype. The factor X (F10) genes of 14 unrelated individuals with factor X deficiency (12 familial and two sporadic cases) were sequenced yielding a total of 13 novel mutations. Family studies were performed in order to distinguish the contributions of individual mutant F10 alleles to the clinical and laboratory phenotypes. Missense mutations were studied by means of molecular modelling, whereas single basepair substitutions in splice sites and the 5' flanking region were examined by in vitro splicing assay and luciferase reporter gene assay respectively. The deletion allele of a novel hexanucleotide insertion/deletion polymorphism in the F10 gene promoter region was shown by reporter gene assay, to reduce promoter activity by approximately 20%. One family manifesting an autosomal dominant pattern of inheritance possessed three clinically affected members who were heterozygous for a splice-site mutation that was predicted to lead to the production of a truncated protein product. A model which accounts for the dominant negative effect of this lesion is presented. Variation in the antigen level of heterozygous relatives of probands was found to be significantly higher between families than within families, consistent with the view that the nature of the F10 lesion(s) segregating in a given family is a prime determinant of the laboratory phenotype. By contrast, no such relationship could be discerned between laboratory phenotype and polymorphism genotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746568     DOI: 10.1007/s004390051035

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

Review 1.  RNA surveillance: molecular approaches in transcript quality control and their implications in clinical diseases.

Authors:  Karen C M Moraes
Journal:  Mol Med       Date:  2009-10-07       Impact factor: 6.354

2.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

3.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

Review 4.  Nonsense-mediated decay in genetic disease: friend or foe?

Authors:  Jake N Miller; David A Pearce
Journal:  Mutat Res Rev Mutat Res       Date:  2014-05-28       Impact factor: 5.657

5.  A novel factor X gene mutation Val (GTC) 384Ala (GCC) in a Chinese family resulting in congenital factor X deficiency.

Authors:  Yanming Wang; Junjie Ma; Xinguang Liu; Yan Wang; Hui Wang; Li Wang; Qiulan Ding; Xiaoxia Chu; Ming Hou
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency.

Authors:  Lara Rizzotto; Mirko Pinotti; Paolo Pinton; Rosario Rizzuto; Francesco Bernardi
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

7.  Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship.

Authors:  Giovanni L Tiscia; Giovanni Favuzzi; Maria R Lupone; Filomena Cappucci; Michele Schiavulli; Valentina Mirabelli; Giovanna D'Andrea; Elena Chinni; Nicola Giuliani; Rocco Caliandro; Elvira Grandone
Journal:  Hum Genome Var       Date:  2017-11-09

8.  Factor X heterozygous mutation in a patient with potential risk of bleeding: A case report.

Authors:  Kotaro Arita; Hideki Niimi; Nana Yamagishi; Tomohiro Ueno; Isao Kitajima; Toshiro Sugiyama
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 9.  Nonsense-mediated RNA decay and its bipolar function in cancer.

Authors:  Gonçalo Nogueira; Rafael Fernandes; Juan F García-Moreno; Luísa Romão
Journal:  Mol Cancer       Date:  2021-04-29       Impact factor: 27.401

10.  Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree.

Authors:  Yuanzheng Feng; Jiewen Ma; Liang V Tang; Wenyi Lin; Yanyi Tao; Zhipeng Cheng; Yu Hu
Journal:  Genes (Basel)       Date:  2021-09-27       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.